News

  • June 18, 2025

    Get Tested

    Human immunodeficiency virus (HIV) is a virus that infects and damages the body’s immune system. HIV remains a persistent problem in the United States. In the United States, in 2022, over 38,000 people received an HIV diagnosis, and an estimated 1.2 million people had HIV. The only way to know your HIV status is to get tested. Knowing your status provides powerful information to help you maintain your health. If your test result is positive, you can take medicine to treat HIV to help you live a long, healthy life and protect others. If your test result is negative, you can take action to prevent HIV. There are many ways to prevent HIV, like using PrEP, PEP, condoms, and never sharing needles. CDC recommends everyone between the ages of 13 and 64 should get tested for HIV at least once. See the Figure below. Individuals with certain risk factors should undergo testing more frequently. Get tested and protect yourself from HIV. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-309-9350 ext. 2 for more information on HIV testing, PrEP, PEP, and treatment.

    Retrieved from https://www.cdc.gov/hiv/resourcelibrary/pocketguides/HIV-Testing-Pocket-Guide_Together-Branded.pdf
    https://www.cdc.gov/stophivtogether/hiv-testing/index.html
    https://www.cdc.gov/hiv/testing/index.html
    https://www.cdc.gov/hiv/about/index.html
    https://www.cdc.gov/hiv-data/nhss/hiv-diagnoses-deaths-prevalence.html
    https://www.cdc.gov/hiv-data/nhss/estimated-hiv-incidence-and-prevalence.html
    https://www.cdc.gov/hiv/data-research/facts-stats/index.html
    https://www.cdc.gov/stophivtogether/hiv-prevention/index.html
    https://www.cdc.gov/stophivtogether/hiv-prevention/prep.html

  • June 11, 2025

    What is PrEP?

    Pre-exposure prophylaxis (PrEP) is the use of antiretroviral medication to prevent HIV. PrEP is for people without HIV who may be exposed to HIV through sex or injection drug use. Cabotegravir (CAB) 600 mg injection (brand name Apretude) is the only approved Injectable HIV PrEP. When taken as prescribed, injectable PrEP with cabotegravir (CAB) is over 99% effective at reducing the risk of getting HIV from sex. Apretude is initially given as an injection into the muscle of your buttock 1 time every month for the first 2 months, then as an injection 1 time every 2 months. CAB injections may be beneficial, especially for people who have problems taking oral PrEP as prescribed, prefer getting a shot every 2 months instead of taking oral PrEP, and have serious kidney disease that prevents the use of oral PrEP medications. See the Figure below. Apretude is for people at risk through sex who weigh at least 77 pounds (35 kg). You must get tested to make sure that you do not already have HIV-1 infection. You must be HIV-1 negative to start Apretude. Apretude is highly effective in preventing HIV when taken as prescribed. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-309-9350 ext. 2 for more information on HIV testing, PrEP, PEP, and treatment.

    Retrieved from https://www.cdc.gov/hivnexus/media/pdfs/2024/04/cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-injectable-hiv-prep.pdf
    https://www.cdc.gov/hivnexus/hcp/prep/index.html
    https://apretude.com/about-apretude/what-is-apretude/
    https://apretude.com/
    https://apretude.com/hiv-risk/understanding-hiv-risk/
    https://apretude.com/risks-and-side-effects/
    https://www.cdc.gov/stophivtogether/hiv-prevention/prep.html
    https://www.cdc.gov/hiv/prevention/prep.html

  • April 24, 2025

    Apretude is the first and only long-acting, injectable PrEP

    Pre-exposure prophylaxis (PrEP) reduces the risk of getting HIV from sex by about 99% and from injecting drugs by at least 74% when taken as prescribed. PrEP can be pills or shots. Truvada and Descovy are the two pills approved for use as PrEP. Cabotegravir (CAB) 600 mg (brand name Apretude) is the only approved injectable PrEP. Apretude is the first and only long-acting, injectable PrEP for reducing the risk of getting HIV. See the Figure below. Injectable PrEP with Apretude is highly effective at protecting patients from HIV and is for adults and adolescents who weigh at least 35 kg (77 lb) and are at risk of getting HIV through sex. Apretude is administered as an intramuscular injection every two months after two initiation injections administered one month apart. Before receiving Apretude, to reduce your risk of getting HIV-1, you must be HIV-1 negative to start Apretude. Do not receive Apretude unless you are tested and confirmed to be HIV-1 negative. Apretude is a good option for PrEP for people who have problems taking oral PrEP as prescribed, prefer getting a shot every two months instead of taking oral PrEP, and people who have serious kidney disease that prevents the use of oral PrEP medications. Apretude is highly effective at protecting people from HIV. Protect yourself from HIV. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-309-9350 ext. 2 for more information on HIV testing, PrEP, PEP, and treatment.

    Retrieved from https://apretude.com/about-apretude/what-is-apretude/
    https://apretude.com/hiv-risk/understanding-hiv-risk
    https://apretude.com/
    https://apretude.com/risks-and-side-effects
    https://www.cdc.gov/hivnexus/media/pdfs/2024/04/cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-injectable-hiv-prep.pdf
    https://www.cdc.gov/stophivtogether/hiv-prevention/prep.html
    https://www.cdc.gov/hiv/prevention/prep.html
    https://www.cdc.gov/hiv/prevention/index.html
    https://www.cdc.gov/hiv/resourcelibrary/infosheets/cdc_hiv_consumer_info_sheet_prep101_2024_508.pdf

  • April 15, 2025

    What is PrEP?

    Pre-exposure prophylaxis (PrEP) is a medication that can help prevent HIV. PrEP is highly effective in preventing HIV. PrEP reduces the risk of getting HIV from sex by up to 99% and from injection drug use by at least 74%. See the Figure below. PrEP is for people who don’t have HIV and are at risk of getting HIV from sex or injection drug use. Truvada and Descovy are the two pills approved for use as PrEP. Cabotegravir (CAB) 600 mg (brand name Apretude) is the only approved injectable PrEP. PrEP is highly effective in preventing HIV when taken as prescribed. Protect yourself from HIV. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-309-9350 ext. 2 for more information on HIV testing, PrEP, PEP, and treatment.

    Retrieved from https://www.cdc.gov/hivnexus/media/pdfs/2024/04/cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-hiv-prep.pdf
    https://www.cdc.gov/hiv/prevention/prep.html
    https://www.cdc.gov/hiv/prevention/index.html
    https://www.cdc.gov/stophivtogether/hiv-prevention/prep.html
    https://www.cdc.gov/hivnexus/media/pdfs/2024/04/cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-injectable-hiv-prep.pdf
    https://apretude.com/
    https://apretude.com/about-apretude/what-is-apretude

  • April 10, 2025

    Do Know Your HIV Status?

    In 2022, over 38,000 people received an HIV diagnosis, and an estimated 1.2 million people had HIV in the United States. The only way to know your HIV status is to get tested. Knowing your HIV status helps you choose options to stay healthy. If your test result is negative, you can take action to prevent HIV. If your test result is positive, you can take medicine to treat HIV to help you live a long, healthy life and protect others. CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once. See the Figure below. People with certain risk factors should get tested more often. Protect yourself from HIV. Get tested. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-3099350 ext. 2 for more information on HIV testing, PrEP, PEP, and treatment.

    Retrieved from https://www.cdc.gov/hiv/resourcelibrary/infosheets/cdc-hiv-consumer-info-sheet-testing-2023-508.pdf
    https://www.cdc.gov/hiv/testing/index.html
    https://www.cdc.gov/hiv-data/nhss/hiv-diagnoses-deaths-prevalence.html
    https://www.cdc.gov/hiv-data/nhss/estimated-hiv-incidence-and-prevalence.html
    https://www.cdc.gov/stophivtogether/hiv-testing/index.html
    https://www.cdc.gov/stophivtogether/index.html
    https://www.cdc.gov/stophivtogether/hiv-testing/talk-testing.html

Events